May 23, 2022, Pfizer-BioNTechfirst announced preliminary results from a Phase 2/3 trial evaluating a three-dose vaccine schedule for children 6 months to less than 5 years of age that will be submitted to the FDA for emergency use authorization (EUA). .
Many mainstream media are praising this development as important to children’s health, writing that “many parents of these very young children were really anxious to get their children vaccinated. strains”2 and “Parents hoping to get their youngest child vaccinated against COVID-19 received some encouraging news on Monday.”3
However, despite the mainstream media’s continued push for parents to vaccinate very young children, the Vaccine Surveillance Survey from KFF4 Only 18% of parents with children under 5 years old plan to have their children vaccinated immediately.
Parents express concern for children’s safety
The KFF reports that a larger number – 38% – are planning to wait and see what side effects the vaccine may have in younger children before making a decision, and 27% said they would definitely not get the shot. for your child. Importantly, the survey also found that “Just over half of parents with children in this age group say they do not have enough information about the safety and effectiveness of vaccines for children under 5 years of age. “.5
Although information about COVID-19 vaccine-related injuries is difficult to find in the mainstream media, it is clear from these numbers that many parents are concerned about safety. of their child and want more information before they are ready to risk their health.
An article published December 15, 2021, at JAMA6 consulted KFF’s previous survey,7 showed that 27% of parents with 5 to 11 year olds are interested in getting their kids to play jab, a 9% drop from the 2022 survey.8 sought to calm the waters with parents hesitant to vaccinate their children, claiming they fear misinformation and misinterpretation of what “EUA” means.
Interestingly, the author of the paper received research grants from Pfizer and Moderna, and also serves on the advisory boards of Johnson & Johnson, Pfizer, and Merck.
The JAMA report said the KFF survey found the main reason parents were concerned were “serious and long-term adverse effects, including future fertility problems”. .9 According to the author, these concerns were addressed and refuted based on one year’s data alone.
Pfizer 80.3% effectiveness based on 10 children
Pfizer’s announcement that it is seeking EUA from the FDA for children 6 months to under 5 years “is based on 10 symptomatic COVID-19 cases identified seven days after the third dose and accumulated since April 29, 2022.”ten
While the study included 1,678 children who received three doses of the formula, the 80.3% efficacy stated in children was based on only 10 cases. This number is so low that even outspoken vaccine advocate Dr. Paul Offit – co-inventor of the rotavirus vaccine11 – expressed disappointment at the number, saying:twelfth
“I mean, 10 kids – you’re talking about 10 kids. It’s a small number, so it’s hard to comment, or is this something more general because you don’t know because the number is so small. ”
Pfizer published these results after delaying the EUA application process to collect more data.13 Initially, the children in the study did not produce a significant immune response after two doses, so the company delayed the request until they could give the children a third dose.
The trial reportedly evaluated the “safety, tolerability, and immunogenicity of three doses of Pfizer-BioNTech COVID-19 Vaccine.”14 Curiously, Pfizer’s claim of 80.3% effectiveness in children is based on a New York State Department of Health study that found the vaccine’s effectiveness in children 5 to 11 years of age had decreased. decreased by 12% two months after vaccination.15
In other words, 7 out of 8 children who received the vaccine did not benefit from the vaccine two months after vaccination. Data taken from 365,502 children showed significant differences between children aged 11 to 12. The effectiveness against infection in 12-year-olds was 67%, but in 11-year-olds, this rate dropped to 11%. .16
Data from the US is consistent with a report from the UK17 showed a 22.6% reduction in efficacy against symptomatic infections after two months in adolescents aged 16 to 17 years.
Interestingly, a Pfizer press release published May 23, 2022, mentioned the word “safe” 22 times while discussing the COVID-19 vaccine for children, and wrote the shot. “well tolerated among 1,678 children under 5 years of age with a safety profile similar to placebo. ”18 The vaccine being used in young children is only one-tenth the strength given to adults.19
However, the Vaccine Adverse Event Reporting System (VAERS)20 recorded 1,878 adverse events in children 5 years of age and 10,029 adverse events in children 6 to 11 years of age from published data as of May 13, 2022.
According to the American Academy of Pediatrics,21 As of May 2022, 35% of children 5 to 11 years of age received one dose and only 28% received both doses of the vaccine. If you extrapolate the side effect numbers using 35% of the population of children who received at least one dose, there would be 34,020 side effects if 100% of children in the US aged 5 to 11 years were vaccinated.
It seems highly unlikely that the 11,907 adverse events in children aged 5 to 11 reported with VAERS after at least one injection would result in only “mild or moderate”22 events occurring in children 6 months to less than 5 years of age or the injection may have a “safety profile similar to that of placebo”.
Moderna is also requesting EUA for children under 5 years old
Moderna is also taking the issue and requiring a low-dose EUA injection for children under the age of 5. The data they submitted showed the vaccine to be effective 37% to 51% of the time against the COVID variant omicron.23
Paul Burton, Moderna’s chief medical officer, speaking to ABC News, said,24 “I think for these young children, they really represent an unmet medical need. I hope that the review will be quick and rigorous – but if it can be approved, this will be made available to these young children as quickly as possible. “
Young children more than likely represent an untapped source of finance for the company, as vaccines have been shown to have dangerous side effects,25 while the infant mortality rate from the infection itself is much lower than in any other age group.26 However, if a vaccine is added to the childhood vaccination schedule and if it is mandated like other childhood vaccines, it will become an evergreen market representing billions of dollars. dollars for pharmaceutical companies.
Every year, the CDC records vaccine effectiveness for flu shots for all vaccines in all age groups. The FDA may find a 37% effectiveness rate for COVID jab acceptable because the adjusted efficacy of the flu vaccine is similar, ranging from 34% to 68% in children 6 months to 8 years of age. from 2015-2016 to the 2019-2020 flu season.27
Although the flu shot is an annual, one-time event, the CDC recommends multiple shots with the COVID vaccine.28 This means that an adult can receive up to five mRNA injections with unknown long-term effects, which have not been shown to effectively protect people against infection. fruit.29
As the effectiveness of the COVID shot in adults and children diminishes in just a few weeks, it is very likely that the same will happen in children aged 6 months to under 5 years. Again, the combination of a mutated virus, impaired immunity, and federal approval of a vaccine is a prime example of an evergreen business model.
More and more Americans are turning away from bumps
According to data released by the CDC,30 82.7% of the US population over the age of 5 has received at least one dose of the COVID vaccine. According to the CDC, this is 258,133,282 people as of May 24, 2022. This is the sound you may have heard in the news. But there are a few other things worth noting.
While the data showed that 70.8% of the population was fully immunized according to the CDC criteria, 11.9% of the population who received the first vaccination did not return for the second dose.
CDC also maintains data on the number of people who received their first booster or second booster, and as of May 24, 2022, 48.4% of eligible people 12 years of age and older had been vaccinated. booster shot and only 20.5% of eligible people 50 years of age or older received a second booster.
It’s important to note that the CDC recommends boosters for people 5 years of age and olderthirty first but they don’t currently track that data publicly. This means that about 17.3% of the population eligible for the vaccine did not receive any doses. When you add that number together with the 11.9% who didn’t return for a second dose, it seems like 29.2% of the population has now decided that they won’t get this vaccine or won’t get one. please other.32
Why are they pushing for the approval of children’s vaccines?
Download interview transcript
In this engaging interview with Alix Mayer, we’ll discuss the nefarious reasons our children are actively targeted for COVID-19 shots, even though CDC data suggests they’re not. must be a serious risk. Mayer is chairwoman of the California chapter’s child health panel and was injured herself from a series of vaccines she received 20 years ago, before leaving the country.
She graduated from Duke University and Northwestern University with an MBA in finance and strategic management. Historically, VAERS has shown that many vaccines have questionable safety profiles, especially when they are combined. However, data from 2021 and 2022 show that there has never been a vaccine as dangerous as the experimental mRNA transgenic injection for COVID.33
The lack of transparency and accountability has been a chronic problem in the industry, but the threats associated with COVID vulnerabilities have really highlighted the issue. Since the shots are still under the EUA, they have a legal immunity from liability for vaccine injury.34
As Mayer pointed out, what you may not realize is that although the FDA appears to have approved and licensed BioNTech’s Comirnaty,35 Footage continues to be managed under the EUA. One reason for this is that once a product is fully licensed, the company is also liable for injuries.36
And, because drug companies understand how dangerous these injections are, they don’t want to be financially responsible for injuries. So, to obtain immunity to a vaccine not administered under the EUA, they must place the product in their childhood immunization schedule, whereby they are not personally liable if the vaccine is not administered. their begging to hurt someone.37,38
Once on the children’s schedule, it also allows the government to mandate the shooting. As Mayer noted, “This is the holy grail if you’re a COVID vaccine maker right now. You want it to be fully licensed, but not put on the market until you get it on the kids schedule.”39
The reason the pharmaceutical industry is pushing to vaccinate young children is clearly based on financial gain. VAERS records show that 117 children under the age of 18 have died from the vaccine and 48,833 reported adverse events and injuries as of May 13, 2022.40
It is important to share this information with parents who are making lifelong decisions for their children and to support your local politicians who have stated goals. is to protect your liberties.
